755 related articles for article (PubMed ID: 23714687)
21. Differential expression of CXCR4 and CXCR7 with various stem cell markers in paired human primary and recurrent glioblastomas.
Flüh C; Hattermann K; Mehdorn HM; Synowitz M; Held-Feindt J
Int J Oncol; 2016 Apr; 48(4):1408-16. PubMed ID: 26821357
[TBL] [Abstract][Full Text] [Related]
22. MiR-152 functions as a tumor suppressor in glioblastoma stem cells by targeting Krüppel-like factor 4.
Ma J; Yao Y; Wang P; Liu Y; Zhao L; Li Z; Li Z; Xue Y
Cancer Lett; 2014 Dec; 355(1):85-95. PubMed ID: 25218589
[TBL] [Abstract][Full Text] [Related]
23. MiR-146b-5p overexpression attenuates stemness and radioresistance of glioma stem cells by targeting HuR/lincRNA-p21/β-catenin pathway.
Yang W; Yu H; Shen Y; Liu Y; Yang Z; Sun T
Oncotarget; 2016 Jul; 7(27):41505-41526. PubMed ID: 27166258
[TBL] [Abstract][Full Text] [Related]
24. Overexpression of miR-29a reduces the oncogenic properties of glioblastoma stem cells by downregulating Quaking gene isoform 6.
Xi Z; Wang P; Xue Y; Shang C; Liu X; Ma J; Li Z; Li Z; Bao M; Liu Y
Oncotarget; 2017 Apr; 8(15):24949-24963. PubMed ID: 28212562
[TBL] [Abstract][Full Text] [Related]
25. Tumor suppressor miR-181c attenuates proliferation, invasion, and self-renewal abilities in glioblastoma.
Ruan J; Lou S; Dai Q; Mao D; Ji J; Sun X
Neuroreport; 2015 Jan; 26(2):66-73. PubMed ID: 25494473
[TBL] [Abstract][Full Text] [Related]
26. ISL1 Promotes Human Glioblastoma-Derived Stem Cells' Self-Renewal by Activation of Sonic Hedgehog/GLI1 Function.
Liu Y; Luan Y; Ma K; Zhang Z; Liu Y; Chen X
Stem Cells Dev; 2022 May; 31(9-10):258-268. PubMed ID: 35403434
[TBL] [Abstract][Full Text] [Related]
27. Cytomegalovirus Immediate-Early Proteins Promote Stemness Properties in Glioblastoma.
Soroceanu L; Matlaf L; Khan S; Akhavan A; Singer E; Bezrookove V; Decker S; Ghanny S; Hadaczek P; Bengtsson H; Ohlfest J; Luciani-Torres MG; Harkins L; Perry A; Guo H; Soteropoulos P; Cobbs CS
Cancer Res; 2015 Aug; 75(15):3065-76. PubMed ID: 26239477
[TBL] [Abstract][Full Text] [Related]
28. The emerging role of tumor-suppressive microRNA-218 in targeting glioblastoma stemness.
Gao X; Jin W
Cancer Lett; 2014 Oct; 353(1):25-31. PubMed ID: 25042866
[TBL] [Abstract][Full Text] [Related]
29. HDAC6 inhibition induces glioma stem cells differentiation and enhances cellular radiation sensitivity through the SHH/Gli1 signaling pathway.
Yang W; Liu Y; Gao R; Yu H; Sun T
Cancer Lett; 2018 Feb; 415():164-176. PubMed ID: 29222038
[TBL] [Abstract][Full Text] [Related]
30. Combined expressional analysis, bioinformatics and targeted proteomics identify new potential therapeutic targets in glioblastoma stem cells.
Stangeland B; Mughal AA; Grieg Z; Sandberg CJ; Joel M; Nygård S; Meling T; Murrell W; Vik Mo EO; Langmoen IA
Oncotarget; 2015 Sep; 6(28):26192-215. PubMed ID: 26295306
[TBL] [Abstract][Full Text] [Related]
31. miR-126-3p sensitizes glioblastoma cells to temozolomide by inactivating Wnt/β-catenin signaling via targeting SOX2.
Luo W; Yan D; Song Z; Zhu X; Liu X; Li X; Zhao S
Life Sci; 2019 Jun; 226():98-106. PubMed ID: 30980849
[TBL] [Abstract][Full Text] [Related]
32. miR-29b attenuates tumorigenicity and stemness maintenance in human glioblastoma multiforme by directly targeting BCL2L2.
Chung HJ; Choi YE; Kim ES; Han YH; Park MJ; Bae IH
Oncotarget; 2015 Jul; 6(21):18429-44. PubMed ID: 26155940
[TBL] [Abstract][Full Text] [Related]
33. miR-145 inhibits migration and invasion of glioma stem cells by targeting ABCG2.
Shi L; Wang Z; Sun G; Wan Y; Guo J; Fu X
Neuromolecular Med; 2014 Jun; 16(2):517-28. PubMed ID: 24777293
[TBL] [Abstract][Full Text] [Related]
34. A curcumin derivative hydrazinobenzoylcurcumin suppresses stem-like features of glioblastoma cells by targeting Ca
Shin HJ; Lee S; Jung HJ
J Cell Biochem; 2019 Apr; 120(4):6741-6752. PubMed ID: 30390339
[TBL] [Abstract][Full Text] [Related]
35. [LincRNA-ROR functions as a ceRNA to regulate Oct4, Sox2, and Nanog expression by sponging miR-145 and its effect on biologic characteristics of colonic cancer stem cells].
Yan ZY; Sun XC
Zhonghua Bing Li Xue Za Zhi; 2018 Apr; 47(4):284-290. PubMed ID: 29690669
[No Abstract] [Full Text] [Related]
36. Hypoxia-inducible miR-196a modulates glioblastoma cell proliferation and migration through complex regulation of NRAS.
Takkar S; Sharma V; Ghosh S; Suri A; Sarkar C; Kulshreshtha R
Cell Oncol (Dordr); 2021 Apr; 44(2):433-451. PubMed ID: 33469841
[TBL] [Abstract][Full Text] [Related]
37. High expression of RFX4 is associated with tumor progression and poor prognosis in patients with glioblastoma.
Jeong HY; Kim HJ; Kim CE; Lee S; Choi MC; Kim SH
Int J Neurosci; 2021 Jan; 131(1):7-14. PubMed ID: 32075484
[No Abstract] [Full Text] [Related]
38. New advances of microRNAs in glioma stem cells, with special emphasis on aberrant methylation of microRNAs.
Zhao B; Bian EB; Li J; Li J
J Cell Physiol; 2014 Sep; 229(9):1141-7. PubMed ID: 24374932
[TBL] [Abstract][Full Text] [Related]
39. NPV-LDE-225 (Erismodegib) inhibits epithelial mesenchymal transition and self-renewal of glioblastoma initiating cells by regulating miR-21, miR-128, and miR-200.
Fu J; Rodova M; Nanta R; Meeker D; Van Veldhuizen PJ; Srivastava RK; Shankar S
Neuro Oncol; 2013 Jun; 15(6):691-706. PubMed ID: 23482671
[TBL] [Abstract][Full Text] [Related]
40. Sialidase NEU4 is involved in glioblastoma stem cell survival.
Silvestri I; Testa F; Zappasodi R; Cairo CW; Zhang Y; Lupo B; Galli R; Di Nicola M; Venerando B; Tringali C
Cell Death Dis; 2014 Aug; 5(8):e1381. PubMed ID: 25144716
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
